MedTrace Logo

Personalize My Treatment (PMT) Registry

NCT02355171 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-02-04

No results posted yet for this study

Summary

The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.

Conditions

Sponsors & Collaborators

  • Exactis Innovation

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2024-12-13

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355171 on ClinicalTrials.gov